Pfizer on Wednesday forecast 2024 sales that were as much as $5 billion below Wall Street expectations due mostly to declining demand for COVID-19 vaccines and treatment, driving shares down ...
Evercore ISI analyst Amit Daryanani upgraded the rating on Dell Technologies Inc. to Outperform from In-Line due to several factors, including what ...